WEIBO Corp: Form 20-F for the period ended Dec 31, 2022
Filed with the SEC on Apr 27, 2023 and accepted by EDGAR at Apr 27, 2023, 06:05 ET.
Sections
Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. The main document on sec.gov.
Figures reported in this filing
Standardized line items from the XBRL in this filing, for the period ended 2022-12-31. Comparative periods it repeats are left out.
| Line item | Period | Value | XBRL concept |
|---|---|---|---|
| Revenue | 12 months2022-01-01 to 2022-12-31 | $1.84bn | us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax |
| Cost of revenue | 12 months2022-01-01 to 2022-12-31 | $400.6m | us-gaap:CostOfGoodsAndServicesSold |
| Research and development | 12 months2022-01-01 to 2022-12-31 | $415.2m | us-gaap:ResearchAndDevelopmentExpense |
| Operating income | 12 months2022-01-01 to 2022-12-31 | $480.5m | us-gaap:OperatingIncomeLoss |
| Interest expense | 12 months2022-01-01 to 2022-12-31 | $71.6m | us-gaap:InterestExpense |
| Income tax | 12 months2022-01-01 to 2022-12-31 | $30.3m | us-gaap:IncomeTaxExpenseBenefit |
| Net income | 12 months2022-01-01 to 2022-12-31 | $85.6m | us-gaap:NetIncomeLoss |
| Diluted EPS | 12 months2022-01-01 to 2022-12-31 | $0.36 | us-gaap:EarningsPerShareDiluted |
| Basic EPS | 12 months2022-01-01 to 2022-12-31 | $0.36 | us-gaap:EarningsPerShareBasic |
| Diluted shares (weighted) | 12 months2022-01-01 to 2022-12-31 | 236,407,000 shares | us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding |
| Operating cash flow | 12 months2022-01-01 to 2022-12-31 | $564.1m | us-gaap:NetCashProvidedByUsedInOperatingActivities |
| Capital expenditure | 12 months2022-01-01 to 2022-12-31 | $43.1m | us-gaap:PaymentsToAcquirePropertyPlantAndEquipment |
| Share repurchases | 12 months2022-01-01 to 2022-12-31 | $57.7m | us-gaap:PaymentsForRepurchaseOfCommonStock |
| Cash and equivalents | At period end2022-12-31 | $2.69bn | us-gaap:CashAndCashEquivalentsAtCarryingValue |
| Current assets | At period end2022-12-31 | $4.55bn | us-gaap:AssetsCurrent |
| Total assets | At period end2022-12-31 | $7.13bn | us-gaap:Assets |
| Current liabilities | At period end2022-12-31 | $1.22bn | us-gaap:LiabilitiesCurrent |
| Total liabilities | At period end2022-12-31 | $3.74bn | us-gaap:Liabilities |
| Shareholders' equity | At period end2022-12-31 | $3.33bn | us-gaap:StockholdersEquity |
Source: SEC EDGAR, the filing index for accession 0001104659-23-050582. Last ingested by Listed: Oct 28, 2026, 07:35 ET. Listed shows no prices and gives no investment advice.